Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Cancer stem cells (CSCs) are a small population of cells in human malignancies that resemble the biology of human pluripotent stem cells. CSCs are closely related to the critical hallmarks in human cancers, ranging from oncogenesis to disease progression, therapeutic resistance, and overall outcome. Mutations in isocitrate dehydrogenase (IDH) were recently identified as founder mutations for human cancers. An increasing amount of evidence indicates that IDH mutations are closely related to the establishment and maintenance of CSCs. Biosynthesis of oncometabolite, metabolic reprogramming, and epigenetic shifts establish distinctive molecular signatures in IDH-mutated CSCs. Additionally, IDH mutation and IDH-related pathways could be valuable molecular targets to impact the CSC components in human cancers and to improve the disease outcome. © 2022 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.


Yang Zhang, Yang Liu, Fengchao Lang, Chunzhang Yang. IDH mutation and cancer stem cell. Essays in biochemistry. 2022 Sep 16;66(4):413-422

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35611837

View Full Text